Newbury Pharmaceuticals AB (publ) (OM: NEWBRY)
Health Care · Pharmaceuticals · SE
Skr2.20
-0.45% today · -7.1% 1Y
Newbury Pharmaceuticals AB (publ) (OM: NEWBRY) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $6.72M and employs 7 people.
Over the last twelve months the share price has lost 7.1%, trading between 0.76 and 7.88.
Tweenvest scores Newbury Pharmaceuticals AB (publ) across four factors: quality 51/100, value 39/100. Its strongest factor is quality.
NEWBRY price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.72M
- Revenue (TTM)
- $3.80M
- P/E
- —
- EPS
- -0.89
- Dividend yield
- —
- Beta (5Y)
- 1.26
- 52-week high
- Skr7.88
- 52-week low
- Skr0.76
- Avg volume (3M)
- —
- Shares outstanding
- 30.40M
- Employees
- 7
- Next earnings
- —
About Newbury Pharmaceuticals AB (publ)
Newbury Pharmaceuticals AB (publ), a hybrid pharmaceutical enterprise, serves both the Swedish and wider Scandinavian markets. Formed in 2020 and headquartered in Lund, Sweden, the company provides a variety of therapeutic solutions, with a strong emphasis on oncology, rare diseases, and neurology, in addition to other treatment categories.
- ISIN
- SE0015244884
- Founded
- 2020
- Listed since
- Feb 4, 2022
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Onyx Biotec LimitedNSEI: ONYX | $7.12M | Rs38.00 | +1.20% |
| Cann Group LimitedASX: CAN | $6.95M | AU$0.01 | +33.33% |
| Traws Pharma, Inc.NasdaqCM: TRAW | $6.84M | $0.42 | -6.78% |
| Epsilon Healthcare LimitedASX: EPN | $6.79M | AU$0.03 | -3.85% |
| PreveCeutical Medical Inc.CNSX: PREV | $6.71M | CA$0.02 | -25.00% |
| Cian Healthcare LimitedBSE: 542678 | $6.70M | Rs25.95 | +6.00% |
| Reviva Pharmaceuticals Holdings, Inc.OTCPK: RVPH | $6.56M | $0.50 | +1.02% |
| Enveric Biosciences, Inc.NasdaqCM: ENVB | $6.49M | $1.47 | +1.38% |
Figures last refreshed Oct 11, 2026.